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ABSTRACT
For more than half a century, researchers have
studied the basic biology of Adenovirus (Ad),
unraveling the subtle, yet profound, interactions
between the virus and the host. These studies
have uncovered previously unknown proteins and
pathways crucial for normal cell function that the
virus manipulates to achieve optimal virus replica-
tion and gene expression. In the infecting virion, the
viral DNA is tightly condensed in a virally encoded
protamine-like protein which must be remodeled
within the first few hours of infection to allow
for efficient expression of virus-encoded genes
and subsequent viral DNA replication. This review
discusses our current knowledge of Ad DNA–
protein complex within the infected cell nucleus,
the cellular proteins the virus utilizes to achieve
chromatinization, and how this event contributes
to efficient gene expression and progression of
the virus life cycle.
INTRODUCTION
Human Adenovirus (Ad) was ﬁrst isolated from adenoid
tissue in the 1950s as novel viral agents associated with
respiratory infections (1,2). Over 100 Ad family members
have been identiﬁed and characterized in a wide range of
host organisms, from a variety of mammals and birds, to
reptiles and amphibians (3). In the early 1960s, researchers
showed that some human Ads can cause tumours in
rodents (4,5), which led to a surge in studies of the
molecular biology, genetics and physiology of Ads which
continues to this day. Since Ads must manipulate the host
cell to promote a microenvironment conducive to virus
replication, studies of basic Ad biology have contributed
a great deal of novel insight into all ﬁelds of cellular
biology, including DNA replication, tumourigenesis and
control of gene expression in the host cell.
While the pool of knowledge regarding the Ad lifecycle
is immense, few studies have investigated the structure
and protein association of Ad DNA within the infected
cell nucleus. Considering the fundamental importance of
chromatin in regulating gene expression in host cells, it is
surprising that, until recently, it remained unclear whether
Ad DNA interacted with cellular histones or assembled
into chromatin. This review summarizes our current
knowledge of the nucleoprotein structure of the Ad
genome within the infected cell.
ADENOVIRUS BIOLOGY
All Ads have the same general structural characteristics.
The virion is a non-enveloped icosahedral capsid with
a diameter of 80–90nm, containing a linear double
stranded DNA genome of 30–40kb (Figure 1) (3).
Of the human Ads, serotype 2 (Ad2) and 5 (Ad5), both
of subclass C, are the most extensively characterized. The
Ad5 genome is 36kb in size and encodes 39 genes,
which are classiﬁed as either early or late depending on
whether they are expressed before or after DNA replica-
tion (Figure 1A) (6). Four early transcription units (E1a,
E1b, E3 and E4) encode proteins that are required
for transactivating other viral regions, modifying the
host cellular environment or altering the immune
response. E2 encodes proteins directly involved in viral
DNA replication. All major late proteins, organized in
the transcription units L1 to L5, are expressed from a
common major late promoter and are generated by alter-
native splicing of a single transcript. However, recent
work has shown that the L4-22K and L4-33K proteins,
which are themselves involved in regulation of the
major late promoter, are initially expressed from a novel
promoter (7). The late transcripts generally encode virion
structural proteins. Four other small late transcripts
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structural protein), IVa2 (encodes a protein involved in
encapsidating the viral DNA into the immature virion)
and VA RNA I and II (the RNA itself blocks activation
of the interferon response). Inverted terminal repeats
(ITR) of 100bp ﬂank both ends of the viral DNA and
contain the origins of replication. Directly adjacent to the
left ITR is the viral packaging sequence (150bp).
The genome organization is relatively conserved through
all Ad species.
The Ad5 capsid is composed of three major (II, III and
IV) and ﬁve minor (IIIa, IVa2, VI, VIII and IX) polypep-
tides (Figure 1B) (8–11). The facets are composed primar-
ily of hexons (trimers of protein II) with pentons (ﬁve
molecules of protein III) capping each vertex. The latter
is the base from which extends ﬁbre (trimer of protein IV),
the distinctive projections at the Ad capsid vertices.
Within the capsid, the viral DNA is associated with
three highly basic proteins, core proteins VII, V and Mu
(m) (12–14). Protein VII is a protamine-like protein and
is responsible for wrapping and condensing the viral
DNA (15). The protein VII-DNA nucleoprotein complex
is organized into a central dense core with 12 large spher-
ical nucleoprotein projections, termed adenosomes, which
extend into each vertex (16,17). A shell of protein V is
thought to coat the protein VII-DNA complex (16,18).
Protein V is believed to make contact with the outer
capsid in several different ways; protein V interacts
directly with penton, and indirectly with peripentonal
hexon and the remainder of hexon bridged through
IIIa and protein VI, respectively (10,11,19–22). Mu is
synthesized as a 79 amino acid precursor protein,
pre-Mu, which is cleaved by the Ad-encoded proteinase
to its ﬁnal 19 amino acid, highly basic mature form (23).
Pre-Mu is speculated to interact with and aid in tightly
condensing the viral DNA within the capsid, and cleavage
of pre-mu may serve to partially relax this structure prior
to its entry into the nucleus (24). Although the viral DNA
does not interact directly with the major capsid proteins
(10,25,26), the DNA still appears to contribute to the
physical stability to the virion; packaging of subgenomic
sized DNA [<90% of the wild-type (wt) genome length]
results in virions that are less stable than wtAd (27,28).
Many of the details of Ad5 infection of cells have
been elucidated. Initially, the Ad ﬁbre protein binds to
the Coxsackie-Adenovirus receptor (CAR), which is the
primary receptor for both Ad5 and Coxsackie B virus
(29,30). This binding is followed by a secondary inter-
action between Ad penton and avb3 or avb5 integrins
(31). Recent studies have shown that Ad5 can enter cells
using heparin sulfate proteoglycans as an alternative
receptor, either through direct binding to the Ad ﬁbre
shaft (32), or bridged through interaction of Ad with
blood factors such as factor IX, factor X or complement
component C4-binding protein (33–35). Ad is internalized
by receptor-mediated endocytosis and evades degradation
by escaping from the early endosome (36). The virion is
transported through the cytoplasm to the nucleus along
the microtubule network (36), and the capsid is slowly
disassembled en route (37). Upon reaching the nuclear
pore complex, the protein VII-wrapped Ad DNA enters
the nucleus (14,37,38), while the rest of the capsid remains
at the nuclear membrane and is subsequently degraded.
Viral DNA replication and assembly of progeny virions
occur entirely within the nucleus of infected cells. The life
cycle takes 24–36h, although the time for completion of
the lifecycle is slightly extended in primary cells. A single
cell infected with a single virus can produce 10
4 daughter
virions.
EARLY EVENTS WITHIN THE INFECTED CELL
NUCLEUS
An overview of our current understanding of Ad DNA
chromatin state in the infected cell is shown in Figure 2.
Although a number of Ad capsid proteins reach the
nucleus, it is only the protein VII-wrapped DNA that
enters the nucleus (14). Histone H1 (H1) escorts the Ad
DNA–protein complex through the nuclear pore (39);
however, this function appears to be independent of any
structural role for H1 on the viral DNA. During this
phase of infection, protein VII protects the viral DNA
from activating the DNA damage response (40). The
ultimate fate of protein VII after entry into the nucleus
is currently a topic of debate. Some studies suggest that
Figure 1. Schematic of the adenovirus genome and virion. (A)A
simpliﬁed map of the Ad5 genome showing the early genes (E1–E4)
and the region from which the major late transcript is produced (the
extensively spliced L1–L5 transcripts produced from alternative splicing
of the major late transcript are not shown). The relative position of
pIX, VA RNA I and II and IVa2 are indicated. Also shown are the
viral inverted terminal repeats (ITR) located at each end of the genome,
the viral packaging element () located adjacent to the left ITR,
and the position of the major late promoter (MLP). Please note that
these features are not drawn to scale. (B) Model of the Ad5 virion,
adapted from (9), with modiﬁcations based on additional data provided
by (8,10,11).
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the early phase of infection (14,41), while other groups
suggest that VII is removed gradually from at least
certain regions of the genome during this same time
period (42,43). Other reports have shown that the
overall level of VII within the infected cell declines
rapidly within the ﬁrst few hours of infection with a con-
comitant decline in VII association with viral genomes
(44). Whether the eviction of protein VII requires active
transcription of the Ad genome is also in dispute
(41,44,45).
Cell-free systems developed to study Ad DNA replica-
tion have shown that the compacted nature of the
VII-wrapped viral DNA allows for only limited transcrip-
tion and DNA replication (46,47). This observation
suggests that the core/DNA structure must be remodeled
to allow these processes to proceed with greater efﬁciency.
Three cellular proteins have been identiﬁed that can
remodel the Ad core in these cell-free systems: template
activating factor Ib (TAF-Ib) [also known as SET (46)],
TAF-II [NAP-1 (48)] and TAF-III [B23/nucleophosmin
(49)]. Using the cell-free system, all three TAF’s were
shown to stimulate replication from the Ad core, while
TAF-Ib and TAF-II were also shown to enhance
transcription. TAF-1b, the best characterized TAF in the
context of Ad core remodeling, forms a tertiary complex
with the VII-wrapped DNA (41,50,51), which results in
increased accessibility of the viral DNA to nucleases and
restriction enzymes and, presumably, transcriptional
activators (47). It is not clear if increased accessibility
was due to actual removal or only shifting of VII on the
DNA template. siRNA-mediated knockdown of TAF-Ib
in infected cells delayed virus gene expression, DNA rep-
lication and virus yield (42), although the effect was
relatively modest. Knockdown of TAF-Ib did not affect
the binding level of protein VII on viral DNA as assessed
by chromatin immunoprecipitation (ChIP), at least at
4hpi (43). Thus, additional proteins are likely involved
in preparing the Ad core for efﬁcient gene expression
and DNA replication within the infected cell nucleus.
Several lines of evidence suggest that VII remains
associated with Ad DNA during the early stage of infec-
tion. First, VII can be cross-linked to the viral DNA at
virtually all stages of infection (52). Second, based on
immunoﬂuorescence analysis, foci of VII can be
observed in the nucleus of infected cells, which represent
Figure 2. Adenovirus DNA chromatin structure throughout infection. In black—elements that we know. In blue and italics—speculation/areas of
future research. DNA in the Ad capsid is highly condensed with core protein VII (1), along with protein V andm (not shown). The protein VII-DNA
complex transits to the nucleus (2), and undergoes remodeling to decondense the core before transcription of early genes can begin (3). Remodeling
may involve loss of at least some VII. At the time when viral gene expression is ﬁrst detected, histones can be found bound to the viral DNA along
with VII. Histone variant H3.3 is preferentially deposited on the viral DNA, through the action of HIRA and CHD1 (4). Onset of viral DNA
replication may be accompanied by a shift to deposition of H3.1 by the CAF1 complex on the DNA, as is observed for HSV1 (5). As the histone
pool is depleted and the intracellular levels of newly synthesized pre-protein VII increase, there is a transition of Ad DNA association from
nucleosomes to pre-protein VII, possibly mediated by TAF-III (6). The viral DNA condensed with pre-protein VII is packaged into the Ad
capsid (1).
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studies have shown directly that VII is bound to the
viral DNA up to at least 10hpi (41,43,44,51,54). There
is some disagreement in these studies regarding the level of
VII association over time; some studies indicate that VII
association is constant and does not change throughout
the early stage of infection (41,45,52), while others suggest
a gradual (or more rapid) decline in VII association with
the viral DNA during this time period (40,43,44,51). Based
on ChIP experiments by Komatsu et al. (43), it appears
that the degree and timing of VII association with the viral
genome during the early phase of infection can vary
depending on the region of the genome that is analysed.
For example, between 1 and 10hpi, VII remains stably
associated with the late-gene hexon coding region, but
shows declining association over time with the major
late promoter (43). This observation somewhat rational-
izes the previous disparate studies. In plasmid-based
in vitro assays, addition of small amounts of protein VII
with the DNA actually enhanced transcription over naked
DNA, suggesting that small quantities of protein VII may
function in part to keep repressive histone/chromatin
features from forming on certain promoter regulatory
elements (43). Taken together, these results suggest that
dynamic regulation of protein VII is necessary for optimal
viral growth; sufﬁcient protein VII must be removed or
remodeled to decondense the viral DNA–nucleoprotein
complex to allow access to the transcription machinery,
but some protein VII must remain to stimulate
transcription.
It is unclear whether transcription through the Ad DNA
template is required for removal or remodeling of VII.
Inhibition of transcription has been correlated with
prolonged retention of VII on the Ad genome (40,45),
although in other studies inhibition of transcription or
transcription elongation did not affect loss of VII
(43,44). Although it has been suggested that de novo
expressed E1A (the ﬁrst viral gene product expressed
within the infected cell) associates with protein VII and
is involved in stimulating transcription on the viral
genome which subsequently strips VII from the viral
DNA (45,54), this function is likely not completely neces-
sary since VII is still removed in the absence of E1A or
active transcription (43,44). It is possible that other
proteins within the cell can perform this function in the
absence of E1A; indeed, E1-deleted Ad can complete a full
replication cycle in certain cell types, although the time
required to complete the replication cycle is extended
(55), suggesting that compensating proteins may exist.
AD DNA ASSOCIATES WITH CELLULAR HISTONES
IN THE INFECTED CELL NUCLEUS
In eukaryotic cells, the basic unit of chromatin is the
nucleosome, with 147bp of DNA wrapped around a
histone octamer, composed of two sets of H2A–H2B
and H3–H4 dimers. The notion that nucleosomes are
simply ‘beads on a string’ has been challenged by the
realization that histones and nucleosomes play key roles
in gene regulation (56). The post-translationally modiﬁed
N-terminal tails of histones serve as docking/recognition
sites for other regulatory proteins (57), providing the epi-
genetic information governing gene expression, as dictated
by the ‘histone code’ (58).
Conﬂicting data from the 1980s suggested that Ad
DNA is or is not associated with cellular histones within
the infected cell (59–63). With the development of more
sensitive techniques, the subject of the Ad nucleoprotein
structure within the infected cell has been revisited
recently. Based on ChIP analysis, Ad and its derivative
vectors (either E1-deleted, replication defective Ad or
helper-dependent Ad [hdAd—devoid of all Ad protein
coding sequences (64)]) do interact with cellular histones
within a few hours of infection (43,44,65). Histones can be
detected on the Ad DNA as early as 1-h post-infection,
and ChIP/re-ChIP experiments show that both protein
VII and histones can be found associated with the same
DNA molecule in the cell (43). Since the histones almost
certainly bind directly to the Ad DNA, at least some VII
must be removed from the viral DNA at these time points
to allow for binding of histones. The mechanism by which
VII is removed, and the cellular protein(s) involved in
this process, have yet to be determined.
Within the cell, deposition of cellular histones can
occur either through a replication-coupled or replication-
independent mechanism, and there are speciﬁc histone
variants and chaperones associated with each mechanism
(66). Histone variant H3.1 is expressed exclusively during
S-phase and is deposited on de novo synthesized DNA by
the Chromatin Assembly Factor I (CAF1) complex in
what is considered a replication-coupled mechanism (67).
In contrast, the replacement histone variant H3.3, which
differs from H3.1 by only ﬁve amino acids, is expressed at
all phases of the cell cycle, and is deposited through
a replication-independent mechanism (66). H3.3 is
deposited on actively transcribed genes by the histone
chaperone HIRA, or on speciﬁc regions of the chromo-
some [such as pericentric DNA repeats and on telomeres
(68–70)] by the H3.3 chaperone DAXX (68). The H3.3
variant is also deposited on incoming male pro-nuclear
DNA shortly after fertilization utilizing the histone chap-
erone HIRA (71). Although TAF-Ib can act as a chaper-
one to transfer histones to DNA templates (47), it
does not appear to perform this function during Ad
infection (43).
As Ad can infect both dividing and non-dividing cells
(and only induces cell cycle progression after viral gene
expression has initiated), it suggests that Ad DNA is
likely to be chromatinized by exploiting a mechanism
independent of DNA replication. Chromatin immunopre-
cipitation (ChIP) experiments have recently demonstrated
hdAd and E1-deleted Ad (44), and wtAd (our unpublished
data) DNA preferentially associates with H3 variant
H3.3 as early as 4hpi, suggesting that chromatinization
does indeed occur by a replication-independent mechan-
ism. A preferential association with H3.3 was also found
with Herpes Simplex Virus 1 (HSV1) DNA during the
early phase of infection (72). siRNA-mediated knockdown
of HIRA reduced the total association of H3 with the
hdAd and HSV1 DNA, as well as reducing expression
of virally encoded genes for both viruses, suggesting that
2372 Nucleic Acids Research, 2012,Vol.40, No. 6chromatinization was necessary for efﬁcient expression.
The involvement of the H3.3 chaperone HIRA, and not
DAXX, is consistent with the observation that DAXX is
actively degraded during normal Ad infection (73). As
deposition of H3.3 on Ad (44) and on HSV1 (72) was
dependent on HIRA, it suggests a common mechanism
for deposition of histones on the genomes of invading
dsDNA nuclear viruses. Moreover, the similarity
between the chromatinization of sperm DNA and
nuclear virus DNA suggests that both use a similar
pathway to achieve chromatinization in the absence of
cellular DNA replication. In vitro observations suggest
that histone chaperones, such as HIRA, either do not
assemble nucleosomes or assemble them at a greatly
reduced rate in the absence of ATP-utilizing factors (74).
In the male pronucleus, HIRA is necessary for delivery
of H3.3 to the site of nucleosome formation (71,75), but
it is the ATP-dependent chromatin remodeling complex
CHD1 that is required for H3.3 deposition (74). In
HeLa extracts, HIRA interacts directly with CHD1 (74).
Thus, it is likely CHD1 that is directly involved in
deposition of histones on the Ad DNA, although this
has yet to be formally proven.
Work by Komatsu et al. (43) showed that wtAd can be
found associated with all members of the nucleosome,
H2A–H2B and H3–H4, as early as 1hpi which, together
with studies showing Ad DNA in the nucleus is wrapped
in a repeating 200bp structure, suggests that the DNA
may be wrapped in complete, physiologically spaced
nucleosomes (44,59–62,76). The chaperone responsible
for deposition of H2A/H2B is unknown. It has been
estimated that up to 40% of infecting wtAd DNA is con-
tained in nucleosomes at 3hpi, and all regions of the
genome are represented in micrococcal nuclease-protected
fractions (59). The observation that both protein VII and
histones can be found bound to the same viral DNA
molecule at the same time suggests that the viral chroma-
tin may not completely resemble that of the host cell (43).
Interestingly, HSV1 genomic DNA associates with
regularly spaced nucleosomes in a latent infection, but
the spacing becomes ‘unstable’ during a lytic infection
and generates heterogeneously sized fragments upon
MNase digestion (77). Whether wtAd assembles into
stable or unstable chromatin during a productive infection
remains to be determined. Electron microscopy analysis of
viral genomes isolated during late time points of infection
(16–18hpi) showed irregularly spaced nucleosome-like
particles at approximately one-tenth the density of
cellular chromatin in HeLa cells [3 versus 26 nucleosomes
permm of DNA, respectively (61)]. However, it is not clear
whether this is due to ‘unstable’ chromatin or the limited
quantities of histones that are available late in Ad infec-
tion. During the replicative phase of the HSV1 lifecycle,
there is a switch from early association with H3.3 to
deposition of H3.1 (72). Whether a similar phenomenon
occurs with wtAd has yet to be determined. The observa-
tion that Ad-induced shut-off of host protein synthesis
results in a reduction in histone gene expression (78,79)
suggests that the virus may simply switch from association
of nucleosomes containing H3.3 to re-deposition of
pre-protein VII in preparation for DNA packaging into
the viral capsid at the ﬁnal stage of the virus lifecycle
(discussed below).
THE IMPORTANCE OF AD DNA
CHROMATINIZATION
Since Ad DNA is chromatinized, this suggests that epigen-
etic regulation may be as important for expression of
Ad-encoded genes as is it for expression of genes
encoded by the host cell. ChIP analysis showed that
there was an increase over time in the level of associ-
ation of acetylated H3 at all Ad promoters tested (43).
Since acetylated histones are commonly associated with
actively transcribed genes, it suggests that as these
promoters become active, they adopt an epigenetic
status similar to cellular genes, which may aid in recruiting
appropriate co-factors for optimal gene expression.
Interestingly, the cell also uses an epigenetic approach in
an attempt to down-regulate expression from some
foreign, invading DNAs, including Ad. Indeed, DAXX
can act as an anti-Ad defense factor and down-regulate
gene expression during wtAd infection (73,80).
Thus, Ad-induced degradation of DAXX at late times
during infection may be a mechanism that the virus uses
to evade down-regulation of its expressed genes (73).
A similar phenomenon occurs for vectors based on Ad
(65), and this can affect vector function in vitro and
in vivo (81). In these latter studies, the vector chromatin
was preferentially associated with deacetylated histones,
which is a marker of transcriptionally inactive chromatin
(65); thus the DNA was ‘marked’ to reduce expression of
vector-encoded genes. These observations clearly illustrate
the ongoing battle between host and pathogen, and the
importance of epigenetic regulation of viral DNA at the
chromatin level.
LATE STAGE PROTEIN VII REPLACEMENT
During the ﬁnal stage of virus replication, the viral
DNA must be condensed once again into the compact
structure required for packaging within the viral capsid.
The histones must therefore be displaced from the Ad
DNA and replaced with pre-protein VII, the precursor
of the mature protein VII [the N-terminus of pre-protein
VII is cleaved by the viral-encoded protease during virion
maturation (3)]. Little is known about how this switch
occurs.
In eukaryotic cells, expression and synthesis of new
histones is tightly regulated to coincide with cellular
DNA replication (82). Interestingly, however, there is a
dramatic decline in histone synthesis at late times during
Ad infection (78,79). This puts forth the hypothesis that at
the late stage of infection, the decline of available histones
relative to the increased levels of pre-protein VII leads,
by default, to the deposition of pre-VII on the newly
synthesized viral DNA (60,62,83). Experiments in cell
free systems have shown that simply mixing Ad DNA
and puriﬁed pre-protein VII leads to the formation of an
insoluble complex, suggesting that a speciﬁc cellular
chaperone(s) mediates the placement of pre-protein VII
Nucleic Acids Research,2012, Vol.40, No. 6 2373on Ad DNA (84). Based on co-immunoprecipitation
studies using extracts from infected cells, TAF-III/
nucleophosmin was shown to have a greater afﬁnity for
pre-protein VII than the mature protein VII, suggesting
that TAF-III may be involved in placing pre-protein VII
on the viral DNA (85). In a cell free system, TAF-III was
able to transfer pre-VII onto DNA, suggesting that
TAF-III is indeed a pre-VII chaperone. However,
additional studies are required to further support the
role for TAF-III as a chaperone during normal Ad
infection of a cell.
CONCLUSION
Insight into the mechanism of Ad chromatinization has
the potential to impact three speciﬁc areas of research.
First, Ad is widely used as a gene delivery system for
basic studies and gene therapy applications (64), and
improved understanding of the parameters that aid in
establishing gene expression within the host cell will
improve vector efﬁcacy and safety. Second, Ad is a signiﬁ-
cant and often overlooked human pathogen (86), and
understanding early events in the cell that permit expres-
sion of viral genes may lead to the identiﬁcation of new
therapeutic targets to limit or prevent wtAd-induced
morbidity and mortality. Finally, numerous studies of
basic aspects of Ad biology have contributed signiﬁcantly
to our understanding of how the host cell works (3).
Undoubtedly, delineation of the proteins and pathways
involved in Ad DNA chromatinization will also improve
our understanding of this process within the host cell.
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